Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin
AssigneeZeaVision LLC
InventorsDennis L. Gierhart, Joseph A. Fox
Life of this patent
Estimating the term…
Loading patent…
AssigneeZeaVision LLC
InventorsDennis L. Gierhart, Joseph A. Fox
Estimating the term…
A carotenoid substance called zeaxanthin, when ingested orally at suitable dosages such as 30 to 100 mg/day for a span of 1 to 2 weeks, can provide effective protection against sunburns, and can; give skin a darker tint that emulates a healthy suntan. In tests involving adults, it was found that zeaxanthin dosages of 30 to about 80 mg per day were sufficient to induce: (i) a mild but noticeable tinting, shading, or darkening of skin color, comparable to a mild suntan; (ii) a substantial increase in the person's ability to withstand elevated levels of sun or UV exposure without any subsequent pain or discomfort, and without the subsequent peeling and flaking that characterizes sunburns; and, (iii) an increased ability of reddened and sunburned skin to convert into intact skin that looks browned and healthily tanned. By reducing the amount of exposure to sunlight (or tanning lights) that are required to achieve a desired level of tanning, zeaxanthin can reduce the risks of skin cancer, premature aging or wrinkling, and similar skin problems. Since zeaxanthin also has retina-protecting properties and reduces the risk of a disease called macular degeneration, oral ingestion of these dosages of a zeaxanthin to enhance a tanned appearance and/or to protect against sun damage is believed to pose no health risks, and can offer several benefits due to the anti-oxidant and other activities of zeaxanthin.
A method of providing a darker skin tint that emulates a healthy suntan, comprising the step of periodically or intermittently ingesting zeaxanthin in a quantity which is sufficient to cause a noticeable darkening of skin tint.
A method of reducing risk of skin damage due to ultraviolet radiation, comprising the step of periodically or intermittently ingesting zeaxanthin in a quantity and over a span of time sufficient to cause a measurable increase in a person's ability to withstand a fixed dosage of ultraviolet radiation without suffering erythema.
A method of inhibit adverse effects of ultraviolet radiation on human skin, comprising the step of ingesting zeaxanthin in a sufficient quantity and over a sufficient span of time to cause a measurable decrease of skin susceptibility to damage by ultraviolet radiation.
A method of increasing skin tolerance to ultraviolet radiation on human skin, comprising the step of ingesting zeaxanthin in a sufficient quantity and over a sufficient span of time to cause at least one skin change selected from the group consisting of a noticeable darkening of skin tint, and a measurable increase in minimal erythemal dosage levels.
A method of inhibiting a skin-hypersensitivity side-effect of a therapeutic drug which induces skin-hypersensitivity, comprising the step of ingesting at least about 10 mg of zeaxanthin per day while said therapeutic drug is being taken.
An article of manufacture, comprising a unit dosage formulation which contains (i) a pharmacologically useful quantity of a therapeutic drug which induces skin-hypersensitivity side effects, and (ii) a quantity of zeaxanthin which is effective in reducing skin-hypersensitivity side effects of the therapeutic drug.
An article of manufacture, comprising:
An article of manufacture, comprising:
An article of manufacture, comprising a food substance that is targeted at non-adult market segments, wherein said food substance contains a quantity of zeaxanthin which is sufficient to cause a noticeable darkening of skin tint if a single helping of such food substance is ingested every other day.
An article of manufacture, comprising capsule or tablet containing zeaxanthin in a range of about 30 to about 50 milligrams.
Dependencies are inferred from the claim text.